| 臺大學術典藏 |
2020-05-20T01:06:55Z |
Risk Factors of Healthcare-Associated Multidrug-Resistant ＂Acinetobacter Baumannii＂ Infection
|
Chiao-Erh Chen;Chi-Tai Fang;Hua-Kung Wang; Chiao-Erh Chen; CHI-TAI FANG; Hua-Kung Wang |
| 臺北醫學大學 |
2014 |
Risk Factors of Hepatic Failure After Re-irradiation for Recurrent Hepatocellular Carcinoma
|
Huang, Y.;Chen, S.;Kuo, C.;Ting, L.;Chiou, J. |
| 臺大學術典藏 |
2018-09-10T08:28:55Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang, J.-Y.;Liu, C.-H.;Hu, F.-C.;Chang, H.-C.;Liu, J.-L.;Chen, J.-M.;Yu, C.-J.;Lee, L.-N.;Kao, J.-H.;Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2020-03-31T08:54:38Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Yu C.-J.; LI-NA LEE; Kao J.-H.; Yang P.-C.; Chen J.-M.; Liu J.-L.; Chang H.-C.; Liu C.-H.; Hu F.-C.; Wang J.-Y. |
| 臺大學術典藏 |
2011 |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Yang P.-C.; Kao J.-H.; Lee L.-N.; Yu C.-J.; Chen J.-M.; JANN-YUAN WANG; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L. |
| 臺大學術典藏 |
2020-08-12T06:35:22Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Kao J.-H.; Yang P.-C.; Lee L.-N.; CHONG-JEN YU; Wang J.-Y.;Liu C.-H.;Hu F.-C.;Chang H.-C.;Liu J.-L.;Chen J.-M.;Chong-Jen Yu;Lee L.-N.;Kao J.-H.;Yang P.-C.; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M. |
| 臺大學術典藏 |
2020-12-02T02:34:09Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; Kao J.-H.; Pan-Chyr Yang; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; Kao J.-H.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-05-24T07:20:47Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; CHEN-HUA LIU; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; Kao J.-H.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-04T06:12:08Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; JIA-HORNG KAO; Yang P.-C. |
| 臺大學術典藏 |
2021-03-12T02:28:42Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.;Liu C.-H.;Hu F.-C.;Chang H.-C.;Liu J.-L.;Chen J.-M.;Yu C.-J.;Li-Na Lee;Kao J.-H.;Yang P.-C.; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; LI-NA LEE; Kao J.-H.; Yang P.-C. |
| 臺大學術典藏 |
2021-05-13T07:16:04Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; JONG-MIN CHEN; Yu C.-J.; Lee L.-N.; Kao J.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:07:34Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; CHONG-JEN YU; Lee L.-N.; Kao J.-H.; Yang P.-C. |
| 臺大學術典藏 |
2018-09-10T18:07:44Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai, Y.-H. and Tai, Y.-J. and Hsu, H.-C. and Lee, S.-P. and Chen, Y.-Y. and Chiang, Y.-C. and Chen, Y.-L. and Chen, C.-A. and Cheng, W.-F.; CHI-AN CHEN |
| 臺大學術典藏 |
2020-01-22T07:50:26Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Cheng W.-F.; CHI-AN CHEN; Chen Y.-L.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Tai Y.-J.; Hsu H.-C.; Tai Y.-H.;Tai Y.-J.;Hsu H.-C.;Lee S.-P.;Chen Y.-Y.;Chiang Y.-C.;Chen Y.-L.;Chi-An Chen;Cheng W.-F.; Tai Y.-H. |
| 臺大學術典藏 |
2020-02-06T05:21:53Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Chiang Y.-C.;Chen Y.-Y.;Lee S.-P.;Hsu H.-C.;Tai Y.-J.;Tai Y.-H.; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P. |
| 臺大學術典藏 |
2020-02-14T02:49:42Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.;Tai Y.-J.;Hsu H.-C.;Lee S.-P.;Chen Y.-Y.;Chiang Y.-C.;Chen Y.-L.;Chen C.-A.;Wen-Fang Cheng; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T08:50:31Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H; Tai Y.-J; Hsu H.-C; Lee S.-P; Chen Y.-Y; YING-CHENG CHIANG; Chen Y.-L; Chen C.-A; Cheng W.-F. |
| 臺大學術典藏 |
2020-05-24T06:00:17Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; YU-LI CHEN; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2021-09-27T06:18:44Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.; Tai Y.-J.; HENG-CHENG HSU; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T02:39:53Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.;Tai Y.-J.;Hsu H.-C.;Lee S.-P.;Chen Y.-Y.;Chiang Y.-C.;Yu-Li Chen;Chen C.-A.;Cheng W.-F.; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; YU-LI CHEN; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2021-03-10T02:34:34Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.;Tai Y.-J.;Heng-Cheng Hsu;Lee S.-P.;Chen Y.-Y.;Chiang Y.-C.;Chen Y.-L.;Chen C.-A.;Cheng W.-F.; Tai Y.-H.; Tai Y.-J.; HENG-CHENG HSU; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T06:11:35Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai Y.-H.;Yi-Jou Tai;Hsu H.-C.;Lee S.-P.;Chen Y.-Y.;Chiang Y.-C.;Chen Y.-L.;Chen C.-A.;Cheng W.-F.; Tai Y.-H.; YI-JOU TAI; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; Cheng W.-F. |
| 國立成功大學 |
2017 |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Tai, Y.-H.;Tai, Y.-J.;Hsu, Hsu H.-C.;Lee, S.-P.;Chen, Y.-Y.;Chiang, Y.-C.;Chen, Y.-L.;Chen, Chen C.-A.;Cheng, W.-F. |
| 國立臺灣大學 |
2016 |
Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
|
Lo, Yin; Shen, Li-Jiuan; Chen, Wen-Hwei; Dong, Yaa-Hui; Wu, Fe-Lin Lin; 林慧玲; 沈麗娟 |
| 臺大學術典藏 |
2018-09-10T15:37:04Z |
Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
|
Lo, Y.;Shen, L.-J.;Chen, W.-H.;Dong, Y.-H.;Wu, F.-L.L.; LI-JIUAN SHEN; Lo, Yin; Shen, Li-Jiuan; Chen, Wen-Hwei; Dong, Yaa-Hui; Wu, Fe-Lin Lin |
